FZMD - Fuse Medical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2200
0.0000 (0.00%)
At close: 11:03AM EST
Stock chart is not supported by your current browser
Previous Close0.2200
Open0.2300
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2200 - 0.2200
52 Week Range0.2200 - 0.7500
Volume3,089
Avg. Volume236
Market Cap15.449M
Beta (3Y Monthly)N/A
PE Ratio (TTM)11.58
EPS (TTM)0.0190
Earnings DateNov 14, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Fuse Medical Ranked Number 89 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™

    Fuse Medical, Inc., (FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it ranked number 89 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 25th year. During the selected period Fuse’s revenue grew 1471%.

  • Business Wire

    Fuse Medical Reports Third Quarter 2019 Results

    Fuse Medical, Inc., (FZMD), emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2019, with the United States Securities and Exchange Commission, on Thursday, November 14, 2019. The filing can be found on the Company’s website at http://www.fusemedical.com/investors. Fuse is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace.

  • Business Wire

    Fuse Medical Announces 2019 Annual Shareholder Meeting Results

    Fuse Medical, Inc., (FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the results of its 2019 Annual Shareholder Meeting that was held on Wednesday, June 26, 2019. Election of Directors: All five directors named in the proxy statement were re-elected to serve on the Company’s Board of Directors: Mark W. Brooks, Christopher C. Reeg, William E. McLaughlin, III, Renato V. Bosita Jr., MD and Ricky Raj S. Kalra, MD. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased the shareholders of Fuse have shown their confidence with the Executive team by electing them to serve as Directors for another year.

  • Business Wire

    Fuse Medical Reports First Quarter 2019 Results

    Fuse Medical, Inc., (FZMD), a distributor and an emerging manufacturer of medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our first quarter of 2019 results, with an eleven (11) percentage point increase to gross profit and one (1) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. The filing can be found on the Company’s website at http://www.fusemedical.com/investors.

  • Business Wire

    Fuse Medical Reports Full Year 2018 Financial Results with Record Earnings

    Fuse Medical, Inc., , an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.

  • Business Wire

    OTC Markets Lists Securities of Fuse Medical, Inc. as Exempt from Penny Stock Designation

    Fuse Medical, Inc., , , announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share , is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.